Statement of Use

JELMYTO

UROGEN PHARMA LTD.

Trademark/Service Mark Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88204510
LAW OFFICE ASSIGNED LAW OFFICE 101
EXTENSION OF USE NO
MARK SECTION
MARK mark
LITERAL ELEMENT JELMYTO
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME UROGEN PHARMA LTD.
MAILING ADDRESS 13 HASADNA STREET
CITY RA'ANANA
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Israel
OWNER SECTION (proposed)
NAME UROGEN PHARMA LTD.
MAILING ADDRESS 9 HaTa'asiya Street
CITY Ra'anana
ZIP/POSTAL CODE 4365007
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Israel
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Peter J. Willsey
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ip@brownrudnick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) pwillsey@brownrudnick.com; doakes@brownrudnick.com
DOCKET/REFERENCE NUMBER 35560/4
CORRESPONDENCE INFORMATION (proposed)
NAME Peter J. Willsey
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ip@brownrudnick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) pwillsey@brownrudnick.com; doakes@brownrudnick.com
DOCKET/REFERENCE NUMBER 35560/4
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and compositions for the treatment of urinary tract cancer
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 05/18/2020
FIRST USE IN COMMERCE DATE 05/18/2020
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-7117930229-202005121 11521589514_._Jelmyto_Via l_box_pdf.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\882\045\88204510\xml1\ SOU0002.JPG
       ORIGINAL PDF FILE SPN0-7117930229-202005121 11521589514_._Jelmyto_pro duct_label.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\882\045\88204510\xml1\ SOU0003.JPG
       ORIGINAL PDF FILE SPN0-7117930229-202005121 11521589514_._JELMYTO_pro duct_insert.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\882\045\88204510\xml1\ SOU0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\882\045\88204510\xml1\ SOU0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\882\045\88204510\xml1\ SOU0006.JPG
SPECIMEN DESCRIPTION photograph of product packaging, photograph of product label, product insert
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
TOTAL AMOUNT 100
SIGNATURE SECTION
DECLARATION SIGNATURE /Diana Yankovitch/
SIGNATORY'S NAME Diana Yankovitch
SIGNATORY'S POSITION IP Director
DATE SIGNED 05/30/2020
SIGNATORY'S PHONE NUMBER 972-54-7473174
FILING INFORMATION
SUBMIT DATE Fri May 29 18:31:38 ET 2020
TEAS STAMP USPTO/SOU-XX.XXX.XX.XXX-2
0200529183138614279-88204
510-710dac459d790257953bd
2ae6acd2e2d47dd777256540c
64c8a4fcc77ab5473aa5-DA-3
1375515-20200521092947615
901



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: JELMYTO(Standard Characters, see http://uspto.report/TM/88204510/mark.png)
SERIAL NUMBER: 88204510


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: UROGEN PHARMA LTD., having an address of
      13 HASADNA STREET
      RA'ANANA,
      Israel
Proposed: UROGEN PHARMA LTD., having an address of
      9 HaTa'asiya Street
      Ra'anana, 4365007
      Israel
      Phone:
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 005:
Current identification: Pharmaceutical preparations and compositions for the treatment of urinary tract cancer

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 05/18/2020, and first used in commerce at least as early as 05/18/2020, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) photograph of product packaging, photograph of product label, product insert.

Original PDF file:
SPN0-7117930229-202005121 11521589514_._Jelmyto_Via l_box_pdf.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-7117930229-202005121 11521589514_._Jelmyto_pro duct_label.pdf
Converted PDF file(s) (1 page)
Specimen File1
Original PDF file:
SPN0-7117930229-202005121 11521589514_._JELMYTO_pro duct_insert.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3


The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      Peter J. Willsey
      PRIMARY EMAIL FOR CORRESPONDENCE: ip@brownrudnick.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): pwillsey@brownrudnick.com; doakes@brownrudnick.com

The docket/reference number is 35560/4.
Correspondence Information (proposed):
      Peter J. Willsey
      PRIMARY EMAIL FOR CORRESPONDENCE: ip@brownrudnick.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): pwillsey@brownrudnick.com; doakes@brownrudnick.com

The docket/reference number is 35560/4.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /Diana Yankovitch/      Date Signed: 05/30/2020
Signatory's Name: Diana Yankovitch
Signatory's Position: IP Director
Signatory's Phone: 972-54-7473174

RAM Sale Number: 88204510
RAM Accounting Date: 05/29/2020

Serial Number: 88204510
Internet Transmission Date: Fri May 29 18:31:38 ET 2020
TEAS Stamp: USPTO/SOU-XX.XXX.XX.XXX-2020052918313861
4279-88204510-710dac459d790257953bd2ae6a
cd2e2d47dd777256540c64c8a4fcc77ab5473aa5
-DA-31375515-20200521092947615901



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed